Penumbra Inc (PEN) Stock Price & Analysis

Penumbra Inc (PEN) rose 0.32% to USD 322.17 as of September 8, 2026 at 06:23 UTC, according to Nexqual real-time market data.

PEN last closed at USD 322.17; the session ranged USD 321.77–322.72 on volume of 174,064 shares. Market capitalization is —, with a 52-week range of USD 221.26–362.41 (NYQ). Source: Nexqual, September 8, 2026 at 06:23 UTC.

Key Statistics (as of September 8, 2026 at 06:23 UTC)

Technical Analysis (PEN)

Nexqual's technical model rates PEN "SELL" based on 2 bullish and 4 bearish signals across 128 daily candles, as of September 8, 2026 at 06:23 UTC.

From Penumbra Inc's Latest SEC 10-K Filing (filed 2026-02-25)

Key Strengths & Strategy (as disclosed to the SEC)

• We developed our proprietary aspiration source as a fully-integrated system specifically for mechanical thrombectomy by vacuum aspiration.
• Penumbra System Reperfusion Catheters are the cornerstone of the Penumbra System and are manufactured using a variety of proprietary processes and materials science innovations for use in revascularization of patients with acute ischemic stroke.
• Intellectual Property Our success depends in part on our ability to protect our proprietary technology and intellectual property and operate without infringing the patents and other proprietary rights of third parties.
• In addition, FDA may conduct a preapproval inspection of the manufacturing facility to ensure compliance with the Quality Management System Regulation ("QMSR").

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:23 UTC. This page is informational and not investment advice.